Reducing toxicity of cisplatin in cancer chemotherapy by extracorporeal removal of excess cisplatin

Journal of Medicine

Volumn 33, Issue 1-4, 2002, Pages 119-127

  Ambrus, Clara M ^a,b   Karakousis, Constantine P ^a   Stadler, Agnes ^a   Stadler, Istvan ^a   Ambrus Jr , Julian L ^a   Anthone, Sidney ^a   Ambrus, Julian L ^a  

^a GATES VASCULAR INSTITUTE AT KALEIDA HEALTH   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Cisplatin removal; Device for removal of cisplatin; Melanoma patients; Platinum chelator; Treatment for isolated tumor

Indexed keywords

CHELATING AGENT; CISPLATIN; PLATINUM;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG INDUCED DISEASE; EXTRACORPOREAL CIRCULATION; HUMAN; MELANOMA; NONHUMAN; SYSTEMIC CIRCULATION; VEIN;

ANIMALS; ANTINEOPLASTIC AGENTS; CHELATING AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; DOGS; EXTRACORPOREAL CIRCULATION; HEMOPERFUSION; HUMANS; INFUSIONS, INTRA-ARTERIAL; MELANOMA; NEOPLASMS;

EID: 0041807740     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ambrus, C.M., Ambrus, J.L., Horvath, C., Pedersen, H., Sharma, S., Mirand, E., Guthrie, R. and Paul, T. (1978): Phenylalanine depletion for the management of phenylketonuria. Use of enzyme reactors with immobilized enzymes. Science 201: 837-839.
2. Ambrus, C.M., Anthone, S., Horvath, C.S., Kalghatki, K., Lele, A., Eapen, G., Ambrus, J.L., Ryan, J. and Li, P. (1987): Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria. Ann. Internal Med. 106: 531-537.
3. Ambrus, C.M., Karakousis, C.K., Anthone S., Horvath, C.S., Kalghatgi, K. and Rieders, F. (1988): Device with an immobilized chelator for extracorporeal removal of excess cisdiaminedichloro-platinum from blood. The Pharmacologist 30: A157, 109.7.
4. Ambrus, C.M., Stadler, I., Toumbis, C.A., Stadler, A., Anthone, S., Anthone, R., DeAlarcon, P., Despande, G., Conway, J., Vladutiu, A. and Ambrus, J.L., Jr. (1999): Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine. J. Med. 30: 211-224.
5. Anderson, A. and Ehrsson, H. (1995): Stability of cisplatin and its monohydrated complex in blood, plasma, and ultra filtrate implications of quantitative analysis. J. Pharm. & Biomed. Anal. 13: 639-644.
6. Anthone, S., Ambrus, C.M., Kohli, R., Min, I., Anthone, R., Stadler, A., Stadler, I. and Vladutiu, A.L. (1995): Treatment of aluminum overload using a cartridge with immobilized desferrioxamine. J. Am. Soc. of Nephrology 6: 1271-1277.
7. El-Khateeb, M., Appleton, T.G., Charles, B.G. and Gahan, L.R. (1999): Development of HPLC conditions for valid determination of hydrolysis products of cisplatin. J. Pharmaceut. Science 88: 319-326.
8. Hauscher, F.H., Kanter, P., Cao, S., et al (1998): Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first - and second - generation protection agents. Seminars in Oncology 25(5): 584-599.
9. th Northeast Bioeng. Conference, New Haven 229-232.
10. Karakousis, C.K. and Perez, R.P. (1994): Soft tissue sarcomas in adults. CA Cancer Clin. 44: 200-210.
11. Markman, M. (Ed): Regional Chemotherapy. Humana Press, 2000.
12. Nagai, N., Okuda, R., Kinoshita, M. and Ogara, H. (1996): Decomposition kinetics of cisplatin in human biological fluids. J. Pharmacol. 48: 918-924.
13. Rose, P., Bundy, B., Watkins, E., Thigpan, T., et al (1999): Concurrent cisplatin - based radiotherapy and chemotherapy for locally advanced cervical cancer. NEJM 340: 1144-1152.
14. Thomas, G. (1999): Improved treatment for cervical cancer - concurrent chemotherapy and radio therapy. NEJM 340:1198-1200.